Stock IMNN IMUNON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Imunon, Inc.

Equities

IMNN

US15117N6022

Delayed Nasdaq
Other stock markets
 12:12:06 2024-05-23 pm EDT 		5-day change 1st Jan Change
1.47 USD +3.53% Intraday chart for Imunon, Inc. +5.01% +116.19%
May. 13 Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024
May. 08 IMUNON, Inc. Appoints Stacy R. Lindborg as Chief Executive Officer, Effective May 13, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
IMUNON, INC. Stock Imunon, Inc.
 13.35M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. Charts Imunon, Inc.
  5. Sector Chart